The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Emerging Infectious Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2029
Synopsis
The global Emerging Infectious Disease market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.
This report is a detailed and comprehensive analysis for global Emerging Infectious Disease market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Emerging Infectious Disease market size and forecasts, in consumption value ($ Million), 2018-2029
Global Emerging Infectious Disease market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Emerging Infectious Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Emerging Infectious Disease market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Emerging Infectious Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Emerging Infectious Disease market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott, BioMerieux, Danaher and Orasure, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Emerging Infectious Disease market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
AIDS
Ebola
SARS
Avian Flu
Chikungunya
Zika
Others
Market segment by Application
Clinical Laboratories
Diagnostic Centers
Others
Market segment by players, this report covers
BD
Abbott
BioMerieux
Danaher
Orasure
Qiagen
Quidel
Sysmex
Gen-Probe
Cepheid
Hologic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Emerging Infectious Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Emerging Infectious Disease, with revenue, gross margin and global market share of Emerging Infectious Disease from 2018 to 2023.
Chapter 3, the Emerging Infectious Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Emerging Infectious Disease market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Emerging Infectious Disease.
Chapter 13, to describe Emerging Infectious Disease research findings and conclusion.
The global Emerging Infectious Disease market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.
This report is a detailed and comprehensive analysis for global Emerging Infectious Disease market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Emerging Infectious Disease market size and forecasts, in consumption value ($ Million), 2018-2029
Global Emerging Infectious Disease market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Emerging Infectious Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Emerging Infectious Disease market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Emerging Infectious Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Emerging Infectious Disease market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott, BioMerieux, Danaher and Orasure, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Emerging Infectious Disease market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
AIDS
Ebola
SARS
Avian Flu
Chikungunya
Zika
Others
Market segment by Application
Clinical Laboratories
Diagnostic Centers
Others
Market segment by players, this report covers
BD
Abbott
BioMerieux
Danaher
Orasure
Qiagen
Quidel
Sysmex
Gen-Probe
Cepheid
Hologic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Emerging Infectious Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Emerging Infectious Disease, with revenue, gross margin and global market share of Emerging Infectious Disease from 2018 to 2023.
Chapter 3, the Emerging Infectious Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Emerging Infectious Disease market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Emerging Infectious Disease.
Chapter 13, to describe Emerging Infectious Disease research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Emerging Infectious Disease
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Emerging Infectious Disease by Type
1.3.1 Overview: Global Emerging Infectious Disease Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Emerging Infectious Disease Consumption Value Market Share by Type in 2022
1.3.3 AIDS
1.3.4 Ebola
1.3.5 SARS
1.3.6 Avian Flu
1.3.7 Chikungunya
1.3.8 Zika
1.3.9 Others
1.4 Global Emerging Infectious Disease Market by Application
1.4.1 Overview: Global Emerging Infectious Disease Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clinical Laboratories
1.4.3 Diagnostic Centers
1.4.4 Others
1.5 Global Emerging Infectious Disease Market Size & Forecast
1.6 Global Emerging Infectious Disease Market Size and Forecast by Region
1.6.1 Global Emerging Infectious Disease Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Emerging Infectious Disease Market Size by Region, (2018-2029)
1.6.3 North America Emerging Infectious Disease Market Size and Prospect (2018-2029)
1.6.4 Europe Emerging Infectious Disease Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Emerging Infectious Disease Market Size and Prospect (2018-2029)
1.6.6 South America Emerging Infectious Disease Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Emerging Infectious Disease Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Emerging Infectious Disease Product and Solutions
2.1.4 BD Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BD Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Emerging Infectious Disease Product and Solutions
2.2.4 Abbott Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbott Recent Developments and Future Plans
2.3 BioMerieux
2.3.1 BioMerieux Details
2.3.2 BioMerieux Major Business
2.3.3 BioMerieux Emerging Infectious Disease Product and Solutions
2.3.4 BioMerieux Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BioMerieux Recent Developments and Future Plans
2.4 Danaher
2.4.1 Danaher Details
2.4.2 Danaher Major Business
2.4.3 Danaher Emerging Infectious Disease Product and Solutions
2.4.4 Danaher Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Danaher Recent Developments and Future Plans
2.5 Orasure
2.5.1 Orasure Details
2.5.2 Orasure Major Business
2.5.3 Orasure Emerging Infectious Disease Product and Solutions
2.5.4 Orasure Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Orasure Recent Developments and Future Plans
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business
2.6.3 Qiagen Emerging Infectious Disease Product and Solutions
2.6.4 Qiagen Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Qiagen Recent Developments and Future Plans
2.7 Quidel
2.7.1 Quidel Details
2.7.2 Quidel Major Business
2.7.3 Quidel Emerging Infectious Disease Product and Solutions
2.7.4 Quidel Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Quidel Recent Developments and Future Plans
2.8 Sysmex
2.8.1 Sysmex Details
2.8.2 Sysmex Major Business
2.8.3 Sysmex Emerging Infectious Disease Product and Solutions
2.8.4 Sysmex Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sysmex Recent Developments and Future Plans
2.9 Gen-Probe
2.9.1 Gen-Probe Details
2.9.2 Gen-Probe Major Business
2.9.3 Gen-Probe Emerging Infectious Disease Product and Solutions
2.9.4 Gen-Probe Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Gen-Probe Recent Developments and Future Plans
2.10 Cepheid
2.10.1 Cepheid Details
2.10.2 Cepheid Major Business
2.10.3 Cepheid Emerging Infectious Disease Product and Solutions
2.10.4 Cepheid Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cepheid Recent Developments and Future Plans
2.11 Hologic
2.11.1 Hologic Details
2.11.2 Hologic Major Business
2.11.3 Hologic Emerging Infectious Disease Product and Solutions
2.11.4 Hologic Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hologic Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Emerging Infectious Disease Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Emerging Infectious Disease by Company Revenue
3.2.2 Top 3 Emerging Infectious Disease Players Market Share in 2022
3.2.3 Top 6 Emerging Infectious Disease Players Market Share in 2022
3.3 Emerging Infectious Disease Market: Overall Company Footprint Analysis
3.3.1 Emerging Infectious Disease Market: Region Footprint
3.3.2 Emerging Infectious Disease Market: Company Product Type Footprint
3.3.3 Emerging Infectious Disease Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Emerging Infectious Disease Consumption Value and Market Share by Type (2018-2023)
4.2 Global Emerging Infectious Disease Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Emerging Infectious Disease Consumption Value Market Share by Application (2018-2023)
5.2 Global Emerging Infectious Disease Market Forecast by Application (2024-2029)
6 North America
6.1 North America Emerging Infectious Disease Consumption Value by Type (2018-2029)
6.2 North America Emerging Infectious Disease Consumption Value by Application (2018-2029)
6.3 North America Emerging Infectious Disease Market Size by Country
6.3.1 North America Emerging Infectious Disease Consumption Value by Country (2018-2029)
6.3.2 United States Emerging Infectious Disease Market Size and Forecast (2018-2029)
6.3.3 Canada Emerging Infectious Disease Market Size and Forecast (2018-2029)
6.3.4 Mexico Emerging Infectious Disease Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Emerging Infectious Disease Consumption Value by Type (2018-2029)
7.2 Europe Emerging Infectious Disease Consumption Value by Application (2018-2029)
7.3 Europe Emerging Infectious Disease Market Size by Country
7.3.1 Europe Emerging Infectious Disease Consumption Value by Country (2018-2029)
7.3.2 Germany Emerging Infectious Disease Market Size and Forecast (2018-2029)
7.3.3 France Emerging Infectious Disease Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Emerging Infectious Disease Market Size and Forecast (2018-2029)
7.3.5 Russia Emerging Infectious Disease Market Size and Forecast (2018-2029)
7.3.6 Italy Emerging Infectious Disease Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Emerging Infectious Disease Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Emerging Infectious Disease Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Emerging Infectious Disease Market Size by Region
8.3.1 Asia-Pacific Emerging Infectious Disease Consumption Value by Region (2018-2029)
8.3.2 China Emerging Infectious Disease Market Size and Forecast (2018-2029)
8.3.3 Japan Emerging Infectious Disease Market Size and Forecast (2018-2029)
8.3.4 South Korea Emerging Infectious Disease Market Size and Forecast (2018-2029)
8.3.5 India Emerging Infectious Disease Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Emerging Infectious Disease Market Size and Forecast (2018-2029)
8.3.7 Australia Emerging Infectious Disease Market Size and Forecast (2018-2029)
9 South America
9.1 South America Emerging Infectious Disease Consumption Value by Type (2018-2029)
9.2 South America Emerging Infectious Disease Consumption Value by Application (2018-2029)
9.3 South America Emerging Infectious Disease Market Size by Country
9.3.1 South America Emerging Infectious Disease Consumption Value by Country (2018-2029)
9.3.2 Brazil Emerging Infectious Disease Market Size and Forecast (2018-2029)
9.3.3 Argentina Emerging Infectious Disease Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Emerging Infectious Disease Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Emerging Infectious Disease Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Emerging Infectious Disease Market Size by Country
10.3.1 Middle East & Africa Emerging Infectious Disease Consumption Value by Country (2018-2029)
10.3.2 Turkey Emerging Infectious Disease Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Emerging Infectious Disease Market Size and Forecast (2018-2029)
10.3.4 UAE Emerging Infectious Disease Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Emerging Infectious Disease Market Drivers
11.2 Emerging Infectious Disease Market Restraints
11.3 Emerging Infectious Disease Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Emerging Infectious Disease Industry Chain
12.2 Emerging Infectious Disease Upstream Analysis
12.3 Emerging Infectious Disease Midstream Analysis
12.4 Emerging Infectious Disease Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
